Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF

Bode, D; Semmler, L; Wakula, P; Hegemann, N; Primessnig, U; Beindorff, N; Powell, D; Dahmen, R; Ruetten, H; Oeing, C; Alogna, A; Messroghli, D; Pieske, BM; Heinzel, FR; Hohendanner, F

Hohendanner, F (corresponding author), Charite, Dept Internal Med & Cardiol, Campus Virchow Klinikum,Augustenburgerpl 1, D-13353 Berlin, Germany.; Hohendanner, F (corresponding author), German Ctr Cardiovasc Res DZHK, Berlin, Germany.; Hohendanner, F (corresponding author), Berlin Inst Hlth BIH, Berlin, Germany.

CARDIOVASCULAR DIABETOLOGY, 2021; 20 (1):

Abstract

Background: Sodium-glucose linked transporter type 2 (SGLT-2) inhibition has been shown to reduce cardiovascular mortality in heart failure independen......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索